2024 Q2 Form 10-Q Financial Statement

#000143774924016012 Filed on May 10, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q4
Revenue $72.41M $58.28M $92.01M
YoY Change -15.12% -21.43% -21.9%
Cost Of Revenue $63.75M $53.27M $67.93M
YoY Change -32.11% 1.36% -33.81%
Gross Profit $8.657M $5.007M $24.08M
YoY Change -200.76% -76.84% 58.55%
Gross Profit Margin 11.96% 8.59% 26.17%
Selling, General & Admin $2.290M $1.903M $2.519M
YoY Change 15.42% -17.26% 5.22%
% of Gross Profit 26.45% 38.01% 10.46%
Research & Development $916.0K $906.0K $1.156M
YoY Change -9.04% -15.49% 14.0%
% of Gross Profit 10.58% 18.09% 4.8%
Depreciation & Amortization $2.145M $2.615M $2.612M
YoY Change -17.63% 2.51% 0.31%
% of Gross Profit 24.78% 52.23% 10.85%
Operating Expenses $3.206M $2.809M $3.675M
YoY Change 7.19% -16.7% 7.83%
Operating Profit $5.451M $2.198M $20.40M
YoY Change -147.06% -87.96% 73.23%
Interest Expense $1.487M $35.00K $2.947M
YoY Change 4273.53% 6.06% 81.02%
% of Operating Profit 27.28% 1.59% 14.44%
Other Income/Expense, Net $4.126M $2.764M $1.000K
YoY Change 137.26% -2.57% -200.0%
Pretax Income $9.577M $4.962M $23.35M
YoY Change -197.29% -76.47% 74.2%
Income Tax $6.000K $632.0K -$33.00K
% Of Pretax Income 0.06% 12.74% -0.14%
Net Earnings $9.571M $4.330M $23.38M
YoY Change -197.08% -79.46% 56.59%
Net Earnings / Revenue 13.22% 7.43% 25.41%
Basic Earnings Per Share $0.22 $0.10 $0.53
Diluted Earnings Per Share $0.22 $0.10 $0.53
COMMON SHARES
Basic Shares Outstanding 43.76M 43.76M 43.76M
Diluted Shares Outstanding 43.76M 43.76M

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $115.1M $201.1M $219.4M
YoY Change -30.97% 10.06% 3.14%
Cash & Equivalents $115.1M $201.1M $219.4M
Short-Term Investments $0.00
Other Short-Term Assets $1.509M $2.570M $3.419M
YoY Change -80.42% -69.7% 43.66%
Inventory $29.52M $56.10M $32.98M
Prepaid Expenses $2.190M $3.197M $4.346M
Receivables $33.39M $24.36M $28.41M
Other Receivables $1.960M $1.935M $1.940M
Total Short-Term Assets $183.6M $289.3M $290.5M
YoY Change -33.04% -0.75% 6.13%
LONG-TERM ASSETS
Property, Plant & Equipment $74.07M $72.57M $72.71M
YoY Change -2.14% -5.63% -5.5%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.474M $3.513M $3.824M
YoY Change -22.75% -28.03% -27.19%
Total Long-Term Assets $77.54M $76.09M $76.54M
YoY Change -3.29% -6.96% -6.88%
TOTAL ASSETS
Total Short-Term Assets $183.6M $289.3M $290.5M
Total Long-Term Assets $77.54M $76.09M $76.54M
Total Assets $261.2M $365.4M $367.1M
YoY Change -26.31% -2.11% 3.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.38M $16.63M $22.18M
YoY Change -49.01% -42.68% -22.31%
Accrued Expenses $11.47M $7.112M $4.758M
YoY Change 97.79% 36.59% -13.13%
Deferred Revenue $4.793M $3.251M $3.656M
YoY Change 41.18% -5.96% 2.55%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $33.14M $144.5M $41.34M
YoY Change -26.01% 169.73% -26.3%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $3.305M $3.296M $3.287M
YoY Change 47.81% 95.49% 83.43%
Total Long-Term Liabilities $13.65M $16.04M $15.86M
YoY Change -11.63% 2.8% -6.01%
TOTAL LIABILITIES
Total Short-Term Liabilities $33.14M $144.5M $41.34M
Total Long-Term Liabilities $13.65M $16.04M $15.86M
Total Liabilities $46.79M $160.6M $57.20M
YoY Change -22.32% 132.09% -21.61%
SHAREHOLDERS EQUITY
Retained Earnings $9.571M $0.00 $27.39M
YoY Change -18.41% -100.0% 5291.14%
Common Stock $4.000K $4.000K $4.000K
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $214.4M $204.8M $309.9M
YoY Change
Total Liabilities & Shareholders Equity $261.2M $365.4M $367.1M
YoY Change -26.31% -2.11% 3.12%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income $9.571M $4.330M $23.38M
YoY Change -197.08% -79.46% 56.59%
Depreciation, Depletion And Amortization $2.145M $2.615M $2.612M
YoY Change -17.63% 2.51% 0.31%
Cash From Operating Activities $27.80M -$12.21M $21.51M
YoY Change -711.37% -59.04% 158.4%
INVESTING ACTIVITIES
Capital Expenditures $2.997M $2.273M $1.028M
YoY Change 111.65% -7.56% -5.34%
Acquisitions
YoY Change
Other Investing Activities $1.170M -$1.212M -$4.334M
YoY Change -96.13% -128.01% 1705.83%
Cash From Investing Activities -$1.827M -$3.485M -$5.362M
YoY Change -106.34% -286.56% 304.37%
FINANCING ACTIVITIES
Cash Dividend Paid $2.626M
YoY Change 0.0%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -112.0M -$2.626M -2.626M
YoY Change 4167.96% -0.53% 0.0%
NET CHANGE
Cash From Operating Activities 27.80M -$12.21M 21.51M
Cash From Investing Activities -1.827M -$3.485M -5.362M
Cash From Financing Activities -112.0M -$2.626M -2.626M
Net Change In Cash -86.06M -$18.32M 13.52M
YoY Change -497.85% -40.09% 209.26%
FREE CASH FLOW
Cash From Operating Activities $27.80M -$12.21M $21.51M
Capital Expenditures $2.997M $2.273M $1.028M
Free Cash Flow $24.80M -$14.48M $20.48M
YoY Change -515.93% -55.11% 182.96%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 ff Accounts Receivable Blenders Tax Credit
AccountsReceivableBlendersTaxCredit
8294000 usd
CY2023Q4 ff Accounts Receivable Blenders Tax Credit
AccountsReceivableBlendersTaxCredit
11381000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
41000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
55000 usd
CY2024Q1 ff Accounts Payable Blenders Tax Credit Payables
AccountsPayableBlendersTaxCreditPayables
890000 usd
CY2023Q4 ff Accounts Payable Blenders Tax Credit Payables
AccountsPayableBlendersTaxCreditPayables
890000 usd
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43763243
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43763243
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.1
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.48
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43763243
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43763243
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43763243
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43766536
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
4330000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
21081000 usd
CY2024Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
0 usd
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
22000 usd
CY2024Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-0 usd
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
5000 usd
CY2024Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 usd
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
17000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
21098000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
309880000 usd
CY2024Q1 us-gaap Dividends
Dividends
109408000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
22000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
4330000 usd
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43763243
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43763243
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
2198000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1000 usd
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
2.5
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
23119000 usd
CY2023Q1 us-gaap Effect Of Lifo Inventory Liquidation On Income
EffectOfLIFOInventoryLiquidationOnIncome
0 usd
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 pure
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
0-52577
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-3340900
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
St Louis
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
MO
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
63105
CY2024Q1 dei City Area Code
CityAreaCode
314
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
854-8352
CY2024Q1 dei Security12b Title
Security12bTitle
Common Stock
CY2024Q1 dei Trading Symbol
TradingSymbol
FF
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
43763243
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
201122000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
219444000 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
24359000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
28406000 usd
CY2024Q1 ff Accounts Receivables Related Parties Current
AccountsReceivablesRelatedPartiesCurrent
8000 usd
CY2023Q4 ff Accounts Receivables Related Parties Current
AccountsReceivablesRelatedPartiesCurrent
1000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
56097000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
32978000 usd
CY2024Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
1935000 usd
CY2023Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
1940000 usd
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3197000 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4346000 usd
CY2024Q1 ff Prepaid Expenses Related Parties
PrepaidExpensesRelatedParties
12000 usd
CY2023Q4 ff Prepaid Expenses Related Parties
PrepaidExpensesRelatedParties
12000 usd
CY2024Q1 us-gaap Other Assets Current
OtherAssetsCurrent
2570000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3419000 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
289300000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
290546000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
72572000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
72711000 usd
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3513000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3824000 usd
CY2024Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
76085000 usd
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
76535000 usd
CY2024Q1 us-gaap Assets
Assets
365385000 usd
CY2023Q4 us-gaap Assets
Assets
367081000 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
16628000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
22178000 usd
CY2024Q1 ff Accounts Payables Related Parties Current
AccountsPayablesRelatedPartiesCurrent
42000 usd
CY2023Q4 ff Accounts Payables Related Parties Current
AccountsPayablesRelatedPartiesCurrent
42000 usd
CY2024Q1 ff Contract With Customer Aggregate Liability Current
ContractWithCustomerAggregateLiabilityCurrent
3458000 usd
CY2023Q4 ff Contract With Customer Aggregate Liability Current
ContractWithCustomerAggregateLiabilityCurrent
3863000 usd
CY2024Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
117285000 usd
CY2023Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
10503000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7112000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4758000 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
144525000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
41344000 usd
CY2024Q1 ff Contract With Customer Aggregate Liability Noncurrent
ContractWithCustomerAggregateLiabilityNoncurrent
12114000 usd
CY2023Q4 ff Contract With Customer Aggregate Liability Noncurrent
ContractWithCustomerAggregateLiabilityNoncurrent
12570000 usd
CY2024Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
626000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
0 usd
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3296000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3287000 usd
CY2024Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
16036000 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
15857000 usd
CY2024Q1 us-gaap Liabilities
Liabilities
160561000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
57201000 usd
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
4000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
4000 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
204820000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
282489000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
0 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
27387000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
204824000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
309880000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
365385000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
367081000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
5007000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
21623000 usd
CY2024Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
987000 usd
CY2023Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
1138000 usd
CY2024Q1 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
763000 usd
CY2023Q1 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
1009000 usd
CY2024Q1 ff Related Party Expense
RelatedPartyExpense
153000 usd
CY2023Q1 ff Related Party Expense
RelatedPartyExpense
153000 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
906000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1072000 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
2809000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
204824000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
3372000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
18251000 usd
CY2024Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
2800000 usd
CY2023Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
2336000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
35000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
33000 usd
CY2024Q1 us-gaap Marketable Securities Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments
0 usd
CY2023Q1 us-gaap Marketable Securities Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments
533000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2764000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2837000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4962000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
21088000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
632000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
4330000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
21081000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.1
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.48
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.1
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.48
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43763243
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43763243
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43763243
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43766536
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
4330000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
21081000 usd
CY2024Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
0 usd
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
22000 usd
CY2024Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-0 usd
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
5000 usd
CY2024Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 usd
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
17000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4330000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
21098000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
309880000 usd
CY2024Q1 us-gaap Dividends
Dividends
109408000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
22000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
204824000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
283000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
17000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
304098000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
4330000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
21081000 usd
CY2024Q1 us-gaap Depreciation
Depreciation
2615000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
2551000 usd
CY2024Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
26000 usd
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
626000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-5000 usd
CY2023Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
533000 usd
CY2024Q1 ff Change In Fair Value Of Derivative Instruments And Marketable Securities
ChangeInFairValueOfDerivativeInstrumentsAndMarketableSecurities
-2274000 usd
CY2023Q1 ff Change In Fair Value Of Derivative Instruments And Marketable Securities
ChangeInFairValueOfDerivativeInstrumentsAndMarketableSecurities
4902000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
22000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
283000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
17000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
21081000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
304098000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
4330000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
21081000 usd
CY2024Q1 us-gaap Depreciation
Depreciation
2615000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
2551000 usd
CY2024Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
26000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
24000 usd
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
626000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-5000 usd
CY2024Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-0 usd
CY2023Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
533000 usd
CY2024Q1 ff Change In Fair Value Of Derivative Instruments And Marketable Securities
ChangeInFairValueOfDerivativeInstrumentsAndMarketableSecurities
-2274000 usd
CY2023Q1 ff Change In Fair Value Of Derivative Instruments And Marketable Securities
ChangeInFairValueOfDerivativeInstrumentsAndMarketableSecurities
4902000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
22000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2024Q1 us-gaap Interest Expense Other
InterestExpenseOther
9000 usd
CY2023Q1 us-gaap Interest Expense Other
InterestExpenseOther
8000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4047000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-277000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
7000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-0 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
42473000 usd
CY2024Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-5000 usd
CY2023Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-23000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-1149000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-525000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-5753000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
413000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
0 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
25000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2354000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-270000 usd
CY2024Q1 ff Increase Decrease In Accrued Expenses And Other Current Liabilities Related Parties
IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilitiesRelatedParties
0 usd
CY2023Q1 ff Increase Decrease In Accrued Expenses And Other Current Liabilities Related Parties
IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilitiesRelatedParties
-1000 usd
CY2024Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-861000 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1274000 usd
CY2024Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
0 usd
CY2023Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-114000 usd
CY2024Q1 us-gaap Increase Decrease Of Restricted Investments
IncreaseDecreaseOfRestrictedInvestments
1212000 usd
CY2023Q1 us-gaap Increase Decrease Of Restricted Investments
IncreaseDecreaseOfRestrictedInvestments
-4327000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2273000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2459000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3485000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1868000 usd
CY2024Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
2626000 usd
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
2626000 usd
CY2024Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
-0 usd
CY2023Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
14000 usd
CY2024Q1 us-gaap Interest Expense Other
InterestExpenseOther
9000 usd
CY2023Q1 us-gaap Interest Expense Other
InterestExpenseOther
8000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4047000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-277000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
7000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-0 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
42473000 usd
CY2024Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-5000 usd
CY2023Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-23000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-1149000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-525000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-72000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
5165000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-5753000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
413000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
0 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
25000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2354000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-270000 usd
CY2024Q1 ff Increase Decrease In Accrued Expenses And Other Current Liabilities Related Parties
IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilitiesRelatedParties
0 usd
CY2024Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-861000 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1274000 usd
CY2024Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
0 usd
CY2023Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-114000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12211000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-29810000 usd
CY2024Q1 us-gaap Increase Decrease Of Restricted Investments
IncreaseDecreaseOfRestrictedInvestments
1212000 usd
CY2023Q1 us-gaap Increase Decrease Of Restricted Investments
IncreaseDecreaseOfRestrictedInvestments
-4327000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2459000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3485000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1868000 usd
CY2024Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
2626000 usd
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
2626000 usd
CY2024Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
-0 usd
CY2023Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
14000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2626000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2640000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-18322000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-30582000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
219444000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
175640000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
201122000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
145058000 usd
CY2024Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
109408000 usd
CY2023Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
7877000 usd
CY2024Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
536000 usd
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
258000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2626000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2640000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-18322000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-30582000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
219444000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
175640000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
201122000 usd
CY2024Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
109408000 usd
CY2024Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
536000 usd
CY2024Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
806000 usd
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1219000 usd
CY2024Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
14521000 usd
CY2023Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
15897000 usd
CY2024Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1544000 usd
CY2023Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1128000 usd
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3251000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3656000 usd
CY2024Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
8917000 usd
CY2024Q1 ff Accounts Receivable Blenders Tax Credit
AccountsReceivableBlendersTaxCredit
8294000 usd
CY2023Q4 ff Accounts Receivable Blenders Tax Credit
AccountsReceivableBlendersTaxCredit
11381000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
41000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
12168000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.27 pure
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P33Y
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
74181000 usd
CY2024Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
806000 usd
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1219000 usd
CY2024Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
14521000 usd
CY2023Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
15897000 usd
CY2024Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1544000 usd
CY2023Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1128000 usd
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3251000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3656000 usd
CY2024Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
8917000 usd
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
9318000 usd
CY2024Q1 ff Accounts Receivable Blenders Tax Credit
AccountsReceivableBlendersTaxCredit
8294000 usd
CY2023Q4 ff Accounts Receivable Blenders Tax Credit
AccountsReceivableBlendersTaxCredit
11381000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
41000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
55000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
12168000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.27 pure
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.73 pure
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P33Y
CY2024Q1 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
55000 usd
CY2023Q1 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
55000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
58281000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
74181000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
58281000 usd
CY2024Q1 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
55000 usd
CY2023Q1 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
55000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
58281000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
74181000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
58281000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
74181000 usd
CY2024Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
18057000 usd
CY2024Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
733000 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
611000 usd
CY2024Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
43680000 usd
CY2023Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
25532000 usd
CY2024Q1 us-gaap Inventory Gross
InventoryGross
62470000 usd
CY2023Q4 us-gaap Inventory Gross
InventoryGross
42378000 usd
CY2024Q1 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
6373000 usd
CY2023Q4 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
9400000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
56097000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
32978000 usd
CY2024Q1 us-gaap Effect Of Lifo Inventory Liquidation On Income
EffectOfLIFOInventoryLiquidationOnIncome
0 usd
CY2024Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-3464000 usd
CY2023Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
3405000 usd
CY2024Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1957000 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
745000 usd
CY2024Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
18057000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
16235000 usd
CY2024Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
733000 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
611000 usd
CY2024Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
43680000 usd
CY2023Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
25532000 usd
CY2024Q1 us-gaap Inventory Gross
InventoryGross
62470000 usd
CY2023Q4 us-gaap Inventory Gross
InventoryGross
42378000 usd
CY2024Q1 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
6373000 usd
CY2023Q4 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
9400000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
56097000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
32978000 usd
CY2024Q1 us-gaap Effect Of Lifo Inventory Liquidation On Income
EffectOfLIFOInventoryLiquidationOnIncome
0 usd
CY2024Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-3464000 usd
CY2024Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-1190000 usd
CY2023Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
8307000 usd
CY2023Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
3405000 usd
CY2024Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1957000 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
745000 usd
CY2024Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
533000 usd
CY2023Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
0 usd
CY2024Q1 us-gaap Deposit Liability Current
DepositLiabilityCurrent
4000000 usd
CY2023Q4 us-gaap Deposit Liability Current
DepositLiabilityCurrent
0 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2179000 usd
CY2024Q1 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
1027000 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
281000 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
283000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7112000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4758000 usd
CY2024Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
533000 usd
CY2023Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
0 usd
CY2024Q1 us-gaap Deposit Liability Current
DepositLiabilityCurrent
4000000 usd
CY2023Q4 us-gaap Deposit Liability Current
DepositLiabilityCurrent
0 usd
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1521000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2179000 usd
CY2024Q1 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
1027000 usd
CY2023Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
1346000 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
281000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
389000 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
283000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
844000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7112000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4758000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
632000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7000 usd
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.127 pure
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
4330000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
21081000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43763243
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43763243
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3293
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43763243
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43766536
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.1
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.48
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.1
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.48
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
632000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7000 usd
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.127 pure
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
4330000 usd
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3293
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43763243
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43766536
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.1
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.48
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.1
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.48
CY2024Q1 ff Number Of Ri Ns In Inventory
NumberOfRINsInInventory
2000000 pure
CY2024Q1 ff Rin Fair Market Value
RINFairMarketValue
1624000 usd
CY2024Q1 ff Rin Cost
RINCost
0 usd
CY2023Q1 ff Number Of Ri Ns In Inventory
NumberOfRINsInInventory
0 pure
CY2024Q1 ff Number Of Ri Ns In Inventory
NumberOfRINsInInventory
2000000 pure
CY2024Q1 ff Rin Fair Market Value
RINFairMarketValue
1624000 usd
CY2024Q1 ff Rin Cost
RINCost
0 usd
CY2023Q1 ff Number Of Ri Ns In Inventory
NumberOfRINsInInventory
0 pure
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
58281000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
74181000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
5007000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
21623000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
58281000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
74181000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
5007000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
21623000 usd

Files In Submission

Name View Source Status
0001437749-24-016012-index-headers.html Edgar Link pending
0001437749-24-016012-index.html Edgar Link pending
0001437749-24-016012.txt Edgar Link pending
0001437749-24-016012-xbrl.zip Edgar Link pending
ex_642375.htm Edgar Link pending
ex_642376.htm Edgar Link pending
ex_642377.htm Edgar Link pending
ff-20240331.xsd Edgar Link pending
ff20200331_10qimg001.jpg Edgar Link pending
ff20240331_10q.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
ff-20240331_def.xml Edgar Link unprocessable
ff-20240331_lab.xml Edgar Link unprocessable
ff-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ff20240331_10q_htm.xml Edgar Link completed
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ff-20240331_cal.xml Edgar Link unprocessable